Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ) SHZ
32.94
-0.45(-1.35%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
32.94
-0.45(-1.35%)
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
553
First IPO Date
January 12, 2017
| Name | Title | Pay | Year Born |
| Guangyao Liu | Deputy General Manager | 0 | 1989 |
| Wei Biao Yue | Deputy General Manager | 0 | 1970 |
| Li Qun Wang | Secretary & Deputy GM | 0 | 1988 |
| Xiaowei Li | Accounting Supervisor | 0 | N/A |
| Yuping Cao | GM & Chairman of the Board | 0 | 1964 |
| Jian Ren Chen | Financial Director | 0 | 1969 |
| Mingsheng Feng | Deputy GM & Director | 0 | 1978 |
Nanjing Hicin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, marketing, and sale of pharmaceutical preparations and synthetic chemicals in China. The company offers antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for cardio-cerebral system, and immuno-modulate agents. It also provides technical transferring services. The company also exports APIs; omeprazole sodium and cefepime hydrochloride for injections; and lansoprazole tablets to South-Asian countries, South-American countries, and European countries. Nanjing Hicin Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China.